C12Y 204/01086
Glucosaminylgalactosylglucosylceramide beta-galactosyltransferase
Official title: Glucosaminylgalactosylglucosylceramide beta-galactosyltransferase (2.4.1.86)
C12Y204/01086 (Glucosaminylgalactosylglucosylceramide beta-galactosyltransferase) appears on 6 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 8
- Assignees
- 4
- Inventors
- 17
- Latest grant
- 17 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 2 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 1 | 1 |
| 2021 | 1 | 0 |
| 2022 | 1 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 3 |
| 2025 | 0 | 1 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Genetically engineered strains with reduced byproduct formation17 Feb 2026US 12,553,071 B2Dsm IP Assets B.V.
- Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides9 May 2023US 11,643,675 B2Glycosyn LLC
- Oligosaccharide production5 Apr 2022US 11,293,042 B2Glycom A/S
- Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides29 Jun 2021US 11,046,984 B2Glycosyn LLC
- Oligosaccharide production4 Aug 2020US 10,731,193 B2Glycom A/S
- Hmo producing microorganism with increased robustness towards glucose gradients18 Sep 2025US 2025/0290078 A1
- Genetically engineered strains with reduced byproduct formation12 Dec 2024US 2024/0409972 A1Dsm IP Assets B.V.
- Methods of producting hmo blend profiles with lnfp-1 and 2'-fl as the predominant compounds3 Oct 2024US 2024/0327885 A1
- Methods of producing hmo blend profiles with lnfp-i and lnt as the predominant compounds3 Oct 2024US 2024/0327886 A1
- Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides24 Feb 2022US 2022/0056497 A1Glycosyn LLC
Most cited
By later US patents